OncoSec Medical Inc (ONCS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

OncoSec Medical Inc (ONCS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH321622D
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

OncoSec Medical Inc (OncoSec) is a biotechnology company which provides services to stimulate body's immune system and attack cancer. It's lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. OncoSec is conducting pipeline programs for various indications which include metastatic melanoma, triple negative breast cancer and solid tumors. It is also identifying and developing novel immune-targeting agents for use with the ImmunoPulse platform. The company conducts pre-clinical and clinical studies targeting various cancers in collaboration with various academic medical centers and companies. OncoSec is headquartered in San Diego, California, the US.

OncoSec Medical Inc (ONCS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

OncoSec Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

OncoSec Medical Inc, Medical Devices Deals, 2011 to YTD 2017 10

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

OncoSec Medical Enters into Agreement with Merck Sharp & Dohme 12

OncoSec Medical Enters into Research Agreement with University of Washington 12

Licensing Agreements 13

OncoSec Medical Enters Into Licensing Agreement With USF Research Foundation For Electroporation Intellectual Property 13

Inovio Pharma Enters Into Licensing Agreement With OncoSec Medical 14

Equity Offering 15

OncoSec Medical Raises USD10 Million in Registered Direct Offering 15

OncoSec Medical Raises USD7.5 Million in Private Placement of Shares 16

OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 18

OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 18

OncoSec Medical Completes Private Placement Of Shares For US$12 Million 19

OncoSec Medical Completes Private Placement Of Common Stock For US$7 Million 20

OncoSec Medical Completes Public Offering Of Units For US$8 Million 21

OncoSec Medical Inc-Key Competitors 24

Key Employees 25

Locations And Subsidiaries 26

Head Office 26

Recent Developments 27

Financial Announcements 27

Mar 16, 2017: OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2017 27

Dec 08, 2016: OncoSec Announces First Quarter Financial Results for Fiscal Year 2017 28

Oct 13, 2016: OncoSec Announces Fourth Quarter and Year End Results for Fiscal Year 2016 29

Jun 09, 2016: OncoSec Announces Third Quarter and YTD Results for Fiscal Year 2016 30

Mar 08, 2016: OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2016 and Calendar 2016 Milestones 31

Corporate Communications 32

Sep 06, 2016: OncoSec Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer 32

Apr 15, 2016: OncoSec Announces New Senior Leadership Responsibilities 33

Feb 29, 2016: OncoSec Appoints Sharron Gargosky, PhD, as Head of Clinical Development and Operations 34

Product News 35

04/19/2016: OncoSec Presents Positive Melanoma Clinical Data at American Association for Cancer Research Annual Meeting 2016 35

04/13/2016: OncoSec to Host Webcast and Panel Discussion on New Melanoma Clinical Data 36

Clinical Trials 37

Mar 02, 2016: OncoSec Completes Patient Enrollment in Phase II Extension Study of ImmunoPulse IL-12 in Melanoma 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Figures

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

OncoSec Medical Inc, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

OncoSec Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

OncoSec Medical Inc, Deals By Therapy Area, 2011 to YTD 2017 9

OncoSec Medical Inc, Medical Devices Deals, 2011 to YTD 2017 10

OncoSec Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

OncoSec Medical Enters into Agreement with Merck Sharp & Dohme 12

OncoSec Medical Enters into Research Agreement with University of Washington 12

OncoSec Medical Enters Into Licensing Agreement With USF Research Foundation For Electroporation Intellectual Property 13

Inovio Pharma Enters Into Licensing Agreement With OncoSec Medical 14

OncoSec Medical Raises USD10 Million in Registered Direct Offering 15

OncoSec Medical Raises USD7.5 Million in Private Placement of Shares 16

OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 18

OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 18

OncoSec Medical Completes Private Placement Of Shares For US$12 Million 19

OncoSec Medical Completes Private Placement Of Common Stock For US$7 Million 20

OncoSec Medical Completes Public Offering Of Units For US$8 Million 21

OncoSec Medical Inc, Key Competitors 24

OncoSec Medical Inc, Key Employees 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

OncoSec Medical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16088
Site License
USD 500 INR 32175
Corporate User License
USD 750 INR 48263

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com